PW Medtech GroupFRA:PWE 83 Median PS Value is €0.28 as of Jun. 28, 2026, which is 100% below its 10-year median of 0.36. GuruFocus rates FRA:PWE with a GF Score™ of 83/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review. Among 337 Medical Devices & Instruments companies, PW Medtech Group ranks better than 79.23% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for PW Medtech Group's Median PS Value or its related term are showing as below:
FRA:PWE'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.31 Med: 0.36 Max: 0.45
Current: 0.39
During the past 13 years, the highest Price to Median PS Value of PW Medtech Group was 0.45. The lowest was 0.31. And the median was 0.36.
FRA:PWE's Price-to-Median-PS-Value is ranked better than 79.23% of 337
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs FRA:PWE: 0.39
PW Medtech Group (FRA:PWE) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
PW Medtech Group's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.11
/
0.28
=
0.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group Median PS Value Related Terms
PW Medtech Group Median PS Value Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PWE vs ISRG, BDX, MDLN: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 4.2424.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.066.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (FRA:PWE) has a Median PS Value of €0.28 as of Jun. 28, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PW Medtech Group and its competitors. This is 22% below median its historical median of 0.36. Over the past decade, PW Medtech Group's Median PS Value has ranged from 0.31 to 0.45. According to the industry distribution chart, PW Medtech Group ranks #70 out of 337 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is PW Medtech Group's Median PS Value too high?
PW Medtech Group's current Median PS Value of €0.28 is 22% below median its 10-year median of 0.36. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 0.45. Based on the distribution chart, PW Medtech Group ranks #70 out of 337 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's Median PS Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #70 out of 337 companies for Median PS Value. This places PW Medtech Group in the top 21% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Historically, PW Medtech Group's own Median PS Value has ranged from 0.31 to 0.45 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 337 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PW Medtech Group and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PW Medtech Group's current Median PS Value is €0.28, which is 22% below median its own 10-year median of 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current Median PS Value of €0.28. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 15.4% below its estimated fair value. The current Median PS Value is €0.28, which is 22% below median its 10-year median of 0.36. PW Medtech Group's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current Median PS Value is €0.28 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.11 is trading 15.4% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:PWE:
Median PS Value: €0.28 (22% below median its 10-year median of 0.36)
GF Value™: €0.13 vs. price of €0.11 (15.4% below fair value)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
83GF Score
Get the complete analysis for FRA:PWE
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
